Series C startups in Nanjing, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| SemiDrive | Nanjing | Series C | $50.0M | 2026-09-21 |
| Weikaier Pharmaceutical Technology | Nanjing | Series C | $29.6M | 2026-06-02 |
| Join Silicon | Nanjing | Series C | $14.1M | 2026-01-23 |
| Zenshine Pharma | Nanjing | Series C | $13.7M | 2023-10-13 |
4 rows of the CSV in 5 of its 18 columns.
- The 49 series c startups in Nanjing, China have raised $2.9B in total.
- 7 of them closed their most recent round in the last 12 months, $152.1M combined.
- The largest of those rounds is SemiDrive's $50.0M Series C, dated September 2026.
- Matrix Partners China is an investor in 2 of them, more than any other fund.
- Health care is the most common sector, with 18 companies (37%).
- 4% were founded in 2020 or later; the median founding year is 2014.
- The most common team size is 11 to 50 employees (22% of companies with a recorded size).
- 1 is a unicorn, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
4 of 49| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| SemiDrive Unicorn | SemiDrive develops automotive-grade SoCs, MCUs, and processors for smart vehicles. | Artificial intelligence | Series C | $50.0M | 2026-09-21 | $654.1M | Matrix Partners China, Vertex Ventures | 101 to 250 | 2018 |
| Weikaier Pharmaceutical Technology | Weikaier Pharmaceutical Technology conducts drug research, transfers generic drug technology, and produces and sells pharmaceuticals. | Biotech | Series C | $29.6M | 2026-06-02 | $120.4M | SDIC Venture Capital, Dyee Capital, Nanjing Innovation Capital Group +1 | 501 to 1,000 | 2010 |
| Join Silicon | JoinSilicon provides internet services, vehicle electronics, and server and computing solutions. | Hardware | Series C | $14.1M | 2026-01-23 | $55.6M | SDIC Venture Capital, Boulder Ventures, Zhuoyuan Capital +1 | 11 to 50 | 2021 |
| Zenshine Pharma | Zenshine Pharma develops small molecule drugs for cancer and autoimmune diseases. | Biotech | Series C | $13.7M | 2023-10-13 | $28.7M | Matrix Partners China, Cybernaut Venture Capital, Kunlun Capital +2 | 11 to 50 | 2018 |
Table 1. Series C startups in Nanjing, China: the 4 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 49.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SemiDrive Unicorn | SemiDrive develops automotive-grade SoCs, MCUs, and processors for smart vehicles. | Artificial intelligence | Series C | $50.0M | 2026-09-21 | $654.1M | Matrix Partners China, Vertex Ventures | 101 to 250 | 2018 |
| 2 | Weikaier Pharmaceutical Technology | Weikaier Pharmaceutical Technology conducts drug research, transfers generic drug technology, and produces and sells pharmaceuticals. | Biotech | Series C | $29.6M | 2026-06-02 | $120.4M | SDIC Venture Capital, Dyee Capital, Nanjing Innovation Capital Group +1 | 501 to 1,000 | 2010 |
| 3 | Join Silicon | JoinSilicon provides internet services, vehicle electronics, and server and computing solutions. | Hardware | Series C | $14.1M | 2026-01-23 | $55.6M | SDIC Venture Capital, Boulder Ventures, Zhuoyuan Capital +1 | 11 to 50 | 2021 |
Table 2. Series C startups in Nanjing, China: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Matrix Partners China | Venture capital firm | Beijing, China | 2 | 4% | 1 | SemiDrive |
| 2 | SDIC Venture Capital | Venture capital firm | Xicheng, China | 2 | 4% | 2 | Weikaier Pharmaceutical Technology, Join Silicon |
| 3 | Lenovo Capital and Incubator Group (LCIG) | Venture capital firm | Beijing, China | 2 | 4% | 1 | eCloudTech |
| 4 | Oriental Fortune Capital | Venture capital firm | Shenzhen, China | 2 | 4% | 1 | eCloudTech |
| 5 | Legend Capital | Venture capital firm | Beijing, China | 2 | 4% | ||
| 6 | Vertex Ventures | Venture capital firm | Singapore | 1 | 2% | 1 | SemiDrive |
| 7 | Nanjing Innovation Capital Group | Venture capital firm | Nanjing, China | 1 | 2% | 1 | Weikaier Pharmaceutical Technology |
| 8 | Dyee Capital | Private equity firm | Xiamen, China | 1 | 2% | 1 | Weikaier Pharmaceutical Technology |
| 9 | China Life Private Equity Investment | Private equity firm | Beijing, China | 1 | 2% | 1 | Weikaier Pharmaceutical Technology |
| 10 | Gaorong Capital | Venture capital firm | Wangjing, China | 1 | 2% | 1 | eCloudTech |
| 11 | SIG China (SIG Asia Investments) | Private equity firm | Huangpu, China | 1 | 2% | 1 | eCloudTech |
| 12 | Zijin High-Tech Venture Capital | Venture capital firm | Nanjing, China | 1 | 2% | 1 | eCloudTech |
| 13 | Boulder Ventures | Venture capital firm | Boulder, United States | 1 | 2% | 1 | Join Silicon |
| 14 | Shang Qi Capital | Venture capital firm | Shanghai, China | 1 | 2% | 1 | Join Silicon |
| 15 | Zhuoyuan Capital | Venture capital firm | Shenzhen, China | 1 | 2% | 1 | Join Silicon |
Table 3. Series C startups in Nanjing, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 18 | 37% | $847.6M |
| Hardware | 16 | 33% | $767.3M |
| Biotech | 15 | 31% | $695.1M |
| Software | 7 | 14% | $29.4M |
| Artificial intelligence | 2 | 4% | $654.1M |
| Energy | 2 | 4% | |
| Cybersecurity | 1 | 2% | |
| Fintech | 1 | 2% | |
| Commerce | 1 | 2% |
Table 4. Series C startups in Nanjing, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series C | 49 | 100% | $14.8M |
Table 5. Series C startups in Nanjing, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| September 2026 | 1 | 14% | $50.0M |
| July 2026 | 1 | 14% | $29.5M |
| June 2026 | 2 | 29% | $44.3M |
| May 2026 | 1 | 14% | |
| January 2026 | 1 | 14% | $14.1M |
| December 2025 | 1 | 14% | $14.2M |
Table 6. Series C startups in Nanjing, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 6 | 12% | $137.9M |
| 2025 | 10 | 20% | $99.0M |
| 2024 | 3 | 6% | $30.0M |
| 2023 | 6 | 12% | $19.2M |
| 2022 | 4 | 8% | |
| 2021 | 5 | 10% | $192.9M |
Table 7. Series C startups in Nanjing, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 2 | 4% |
| 2015 to 2019 | 21 | 43% |
| 2010 to 2014 | 17 | 35% |
| Before 2010 | 9 | 18% |
Table 8. Series C startups in Nanjing, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 4 | 9% |
| 11 to 50 | 10 | 22% |
| 51 to 100 | 9 | 20% |
| 101 to 250 | 10 | 22% |
| 251 to 500 | 3 | 7% |
| 501 to 1,000 | 4 | 9% |
| 1,001 to 5,000 | 6 | 13% |
Table 9. Series C startups in Nanjing, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when its most recent funding round is Series C and its headquarters is in Nanjing, China. On 16 November 2026 that is 49 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 4 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 49 rows: 23 have no round amount, 0 no city and 22 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many series c startups in Nanjing, China are on the list?
- 49, in the file dated 16 November 2026. 7 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 49 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.